Location History:
- Kobenhavn K, DK (2020)
- Copenhagen, DK (2018 - 2023)
Company Filing History:
Years Active: 2018-2025
Title: Laurits Hoejgaard Olesen: Innovator in Drug Delivery Systems
Introduction
Laurits Hoejgaard Olesen is a prominent inventor based in Copenhagen, Denmark. He has made significant contributions to the field of drug delivery systems, holding a total of seven patents. His innovative work focuses on enhancing the efficiency and effectiveness of drug delivery mechanisms.
Latest Patents
Olesen's latest patents include a "Drug delivery assembly with moving sensor system." This invention features a magnetic indicator and a sensor system that allows for precise measurement of the expelled dose amount. The indicator rotates and moves axially relative to a housing component, providing valuable data on the size of the dose. The sensor system is designed to measure the rotational position and movement of the indicator, ensuring accurate dosing.
Another notable patent is the "Drug delivery assembly with sensor sampling feature." This assembly combines a sensor system with an indicator that rotates to indicate the size of the expelled dose. The sensor assembly operates at a non-constant sampling frequency, allowing for dynamic control of energy consumption based on the determined rotational speed of the indicator.
Career Highlights
Laurits Hoejgaard Olesen is currently employed at Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk focuses on developing innovative solutions for diabetes care and other chronic conditions. Olesen's expertise in drug delivery systems has positioned him as a key player in advancing medical technology.
Collaborations
Olesen has collaborated with notable colleagues, including Nikolaj Frogner Krusell and Nikolaj Eusebius Jakobsen. These collaborations have contributed to the development of cutting-edge technologies in the field of drug delivery.
Conclusion
Laurits Hoejgaard Olesen is a distinguished inventor whose work in drug delivery systems has the potential to revolutionize patient care. His innovative patents and contributions to Novo Nordisk A/S highlight his commitment to improving healthcare through technology.